CS logo
small CS logo
Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia

Sao Paulo, SP, Brazil
Universidade em São Paulo

About Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Federal University of São Paulo
8
Hoffmann-La Roche
7
Total Rows: 2

Clinical Trials at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia


During the past decade, Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110011331155000000000000Started TrialsCompleted Trails2016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy of Lutein, Zeaxanthine and Trypan Blue to Stain the Anterior Lens Capsule
2012-06-01
2014-05-01
Completed
25
Osmoprotective Containing Lubricants in Dysfunctional Tear Syndrome and Post Refractive Surgery Patients
2008-10-01
2015-08-01
Completed
100
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
2013-01-01
2016-08-01
Completed
100
Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema
2014-03-01
2015-07-01
Withdrawn
0
Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans
2016-02-01
2017-05-01
Completed
24
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis
2019-01-01
2022-03-01
Active, not recruiting
60

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Acácio Alves Souza Lima-Filho" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "André Maia" with 1 trials as a collaborator and "Casa de Saúde São José" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFederal University ofSão Paulo: 8Federal University ofSão Paulo: 8Hoffmann-La Roche: 7Hoffmann-La Roche: 7

Created with Highcharts 11.1.0Top CollaboratorsChugai Pharmaceutical: 2Chugai Pharmaceutical: 2Acácio Alves Souza Lima-Filho: 1Acácio Alves Souza Lima-Filho: 1Allergan: 1Allergan: 1André Maia: 1André Maia: 1Casa de Saúde São José: 1Casa de Saúde São José: 1Eduardo B. Rodrigues: 1Eduardo B. Rodrigues: 1Eduardo Novais: 1Eduardo Novais: 1Emmerson Badaró: 1Emmerson Badaró: 1Luis Filipe Nakayama: 1Luis Filipe Nakayama: 1Mauricio Maia: 1Mauricio Maia: 1

Clinical Trials Conditions at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia


According to Clinical.Site data, the most researched conditions in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" are "Diabetic Macular Edema" (3 trials), "Endophthalmitis" (2 trials), "Macular Edema" (2 trials), "Ametropia" (1 trials) and "Aqueous Deficient Dry Eye Disease" (1 trials). Many other conditions were trialed in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" in a lesser frequency.

Clinical Trials Intervention Types at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia


Most popular intervention types in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" are "Drug" (11 trials), "Procedure" (6 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Ranibizumab" (2 trials) and "Acai dye 10%" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia


The vast majority of trials in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" are 15 trials for "All" genders.

Clinical Trials Status at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia


Currently, there are NaN active trials in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Not Applicable: 4Not Applicable: 4Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 5Active, not recruiting: 5Recruiting: 2Recruiting: 2Unknown status: 1Unknown status: 1Withdrawn: 1Withdrawn: 1